Carisbamate (RWJ-333369) CAS NO.194085-75-1

boc sciences is committed to supplying cost-effective products and services. we provide carisbamate (rwj-333369). carisbamate (ykp 509, proposed trade name comfyde) is an experimental anticonvulsant drug under development by johnson & johnson pharmaceutical research and development. in 1998, the compound was in-licensed from sk corp. (currently life science business division of sk holdings), a south korean company. a phase ii clinical trial in the treatment of partial seizures demonstrated that the compound has efficacy in the treatment of partial seizures and a good safety profile. since late 2006, the compound has been undergoing a large multicenter phase iii clinical trial for the treatment of partial seizures. its mechanism of action is unknown. more information please visit: www.bocsci.com/carisbamate-rwj-333369-cas-194085-75-1-item-468174.html